#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Toxic epidermal necrolysis Autoimmune disorder Haemophilia B with anti factor IX Systemic mastocytosis Endocrine ophthalmopathy Ewing's sarcoma metastatic Craniocerebral injury Alternating hemiplegia of childhood Polymyositis Hereditary motor and sensory neuropathy Endometrial cancer Henoch-Schonlein purpura Cholangitis sclerosing Neurofibromatosis Multifocal motor neuropathy More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis Ewing’s sarcoma recurrent – Diagnostics Hereditary angioedema – Basic Information Krabbe’s disease – Trials in Disease Epidermolysis bullosa Breast angiosarcoma metastatic Bronchiolitis obliterans syndrome – Treatment Medulloblastoma – Life with Disease Rhabdoid tumour – Treatment Soft tissue sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dosulepin Hydrochloride SODIUM DIHYDROGEN PHOSPHATE Dotatate TIFCEMALIMAB Bay 3018250 Rmc-035 Lidocaine Hydrochloride Nacubactam Quinapril Hydrochloride HYPOCHLOROUS ACID Vo659 Idarubicin Hydrochloride Thiamazole Specific Nucleic Acid Sna-Her2 Tasipimidine Ceftazidime Pentahydrate APROTININ Apocynin Cefepime Hydrochloride Amy109 More therapies…

    Learn about Your Condition

    Craniopharyngioma Alagille syndrome Cerebrovascular accident Breast cancer male Aphthous ulcer Liver transplant Gastrooesophageal cancer Chorea Alcohol abuse Myocarditis Traumatic pain Infantile apnoea Hip arthroplasty Tardive dyskinesia Transplant rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    • Rituximab
    Belgium Denmark France Germany Poland Spain

  • Multiple Ascending Dose Safety, Tolerability and Pharmacokinetics of MK-7602 in Healthy Volunteers for Malaria

    Not recruiting

    1 1
    Belgium

  • Efficacy of Tranexamic Acid in Reducing Perioperative Blood Loss in Patients with Hip Fracture: A Randomized, Double-Blind Clinical Trial

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tranexamic Acid
    Spain

  • Safety, tolerability, pharmacokinetics and food effect of BI 3000202 in healthy adult men: a randomised placebo‑controlled single‑dose study

    Not recruiting

    1 1
    Germany

  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous lupus erythematosus
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Enpatoran
    Bulgaria Greece Poland Romania Spain

  • Pharmacokinetic, Safety, and Efficacy Evaluation of ASTX727 and Venetoclax in Adult Patients with Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    • Venetoclax
    Spain
Previous Page
1 … 920 921 922 923 924 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!